4//SEC Filing
Coleman Mark 4
Accession 0000950170-24-066175
CIK 0001579428other
Filed
May 28, 8:00 PM ET
Accepted
May 29, 8:11 PM ET
Size
6.5 KB
Accession
0000950170-24-066175
Insider Transaction Report
Form 4
Coleman Mark
Director
Transactions
- Sale
Common Stock
2024-05-29$75.14/sh−5,248$394,333→ 14,600 total - Sale
Common Stock
2024-05-28$75.21/sh−5,249$394,775→ 19,848 total
Footnotes (4)
- [F1]Such transaction was pursuant to a pre-approved 10b5-1 plan.
- [F2]Represents the sale of underlying shares of previously exercised stock options.
- [F3]Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $75.00 and $75.88.
- [F4]Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $75.00 and $75.90.
Documents
Issuer
Axsome Therapeutics, Inc.
CIK 0001579428
Entity typeother
Related Parties
1- filerCIK 0001658379
Filing Metadata
- Form type
- 4
- Filed
- May 28, 8:00 PM ET
- Accepted
- May 29, 8:11 PM ET
- Size
- 6.5 KB